Cargando…

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

OBJECTIVES: To assess the efficacy and safety of a treatment switch from a twice-daily (BID) regimen containing zidovudine (ZDV) and lamivudine (3TC) plus a third agent to a once daily (QD) regimen containing the fixed-dose combination of tenofovir DF/emtricitabine (TDF/FTC, Truvada(®)) plus a diver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arasteh, K, Weitner, L, Fenske, S, Kuhlmann, B, Freiwald, M, Ebrahimi, R, Gallo, L, Ranneberg, B, Mertenskoetter, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351977/ https://www.ncbi.nlm.nih.gov/pubmed/19541575 http://dx.doi.org/10.1186/2047-783X-14-5-195

Ejemplares similares

5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
por: Lazzarin, A, et al.
Publicado: (2010)

537 STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96
por: Creticos, Catherine, et al.
Publicado: (2014)

QD0 Design
por: Modena, Michele
Publicado: (2013)

QD0 Design
por: Modena, Michele
Publicado: (2013)

Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy and Safety of Switching from Boosted-protease Inhibitors (bPI) Plus Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Regimens to the Once Daily (QD), Single-tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-infected Adults
por: Orkin, Chloe, et al.
Publicado: (2017)

1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-Infected Adults: Week 96 Results of the Phase 3, Randomized, Non-Inferiority EMERALD Trial
por: Eron, Joseph, et al.
Publicado: (2018)

CLIC QD0 "Short Prototype" Status
por: Modena, Michele
Publicado: (2012)

QD-Based FRET Probes at a Glance
por: Shamirian, Armen, et al.
Publicado: (2015)

QD:Puf Nanohybrids Are Compatible with Studies in Cells
por: Wójtowicz, Karolina, et al.
Publicado: (2022)

Efectos adversos de dos esquemas antirretrovirales (ZDV+ 3TC+SQV y ZDV+3TC+ABC) en pacientes VIH/SIDA
por: Lagunes Torres, Teresa de Jesús
Publicado: (2003)

1567 Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48
por: Cunningham, Douglas, et al.
Publicado: (2014)

Considerations for a QD0 with Hybrid Technology in ILC
por: Modena, M, et al.
Publicado: (2014)

Cablage enroulements de correction "QF" et "QD"
por: Pasquali, J
Publicado: (1974)

Switchable Multi-Color Solution-Processed QD-laser
por: Matloub, Samiye, et al.
Publicado: (2020)

Radiation Dose to the QD0 Quadrupole in the CLIC Interaction Region
por: Teodorescu, E, et al.
Publicado: (2011)

Research on the Force-Sensitive Characteristic of InAs QD Embedded in HEMT
por: Wang, Rui-Rong, et al.
Publicado: (2021)

555. Characteristics of HIV+ Patients Prescribed Raltegravir QD in the United States
por: Lackey, Philip, et al.
Publicado: (2018)

Engineering the Band Alignment in QD Heterojunction Films via Ligand Exchange
por: Grimaldi, Gianluca, et al.
Publicado: (2019)

Improved resolution in single-molecule localization microscopy using QD-PAINT
por: Chang, Yeonho, et al.
Publicado: (2021)

Development of Quantum Dot (QD) Based Color Converters for Multicolor Display
por: Sajjad, Muhammad T., et al.
Publicado: (2021)

Direct Laser Writing of Functional QD–Polymer Structure with High Resolution
por: Jue, Jiubin, et al.
Publicado: (2023)

Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
por: Lau, George KK, et al.
Publicado: (2010)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

1614. Efficacy and Safety of Adjusted Renal Dosing of Tenofovir DF Versus Abacavir Switching in HIV Patients with Decreased Glomerular Filtration Rate After Receiving Tenofovir DF-Based Regimen
por: Yamasmith, Eakkawit, et al.
Publicado: (2023)

Case Report: Reversal of Integrase Inhibitor– and Tenofovir Alafenamide–Related Weight Gain After Switching Back to Efavirenz/Emtricitabine/Tenofovir DF
por: Pohlman, F Will, et al.
Publicado: (2021)

2509. Pooled Resistance Analyses of Darunavir (DRV) Once Daily (QD) Regimens and Formulations Across 10 Clinical Studies of Treatment-Naïve (TN) and Treatment-Experienced (TE) Patients with Human Immunodeficiency Virus (HIV)-1 Infection
por: Lathouwers, Erkki, et al.
Publicado: (2019)

Alimentation de reserve pour qf, qd, mos 301, mos 302
por: Fiebiger, H
Publicado: (1976)

Obtaining and doping of InAs-QD/GaAs(001) nanostructures by ion beam sputtering
por: Chebotarev, Sergei N, et al.
Publicado: (2017)

Si-QD Synthesis for Visible Light Emission, Color Conversion, and Optical Switching
por: Cheng, Chih-Hsien, et al.
Publicado: (2020)

A Superimposed QD-Based Optical Antenna for VLC: White LED Source
por: Chamani, Shaghayegh, et al.
Publicado: (2022)

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
por: Juday, Timothy, et al.
Publicado: (2013)

Viral Blips Were Infrequent in HIV-1-Infected Virologically-Suppressed Adults Treated with Tenofovir Alafenamide or Tenofovir DF Rilpivirine-Containing Regimens
por: Wohl, David A, et al.
Publicado: (2017)

Review of tenofovir-emtricitabine
por: Masho, Saba Woldemichael, et al.
Publicado: (2007)

936 Tolerability, Adherence and Completion of New Occupational HIV Post-Exposure Prophylaxis Regimens (Tenofovir + Emtricitabine and Raltegravir)
por: Bock, Izona, et al.
Publicado: (2014)

LB1. Doravirine/Lamivudine/Tenofovir DF Continues to Be NonInferior to Efavirenz/Emtricitabine/Tenofovir DF in Treatment-Naïve Adults With HIV-1 Infection: Week 96 Results of the DRIVE-AHEAD Trial
por: Orkin, Chloe, et al.
Publicado: (2018)

CdSe Quantum Dot (QD)-Induced Morphological and Functional Impairments to Liver in Mice
por: Liu, Wei, et al.
Publicado: (2011)

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
por: Ho, Yi-Ping, et al.
Publicado: (2009)

LiQD Cornea: Pro-regeneration collagen mimetics as patches and alternatives to corneal transplantation
por: McTiernan, Christopher D., et al.
Publicado: (2020)

CdTe QD-based inhibition and reactivation assay of acetylcholinesterase for the detection of organophosphorus pesticides
por: Korram, Jyoti, et al.
Publicado: (2020)

Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DF
por: Gathe, Joseph, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vtv55bj7letjhobqovim5e78go